Founded Year

2015

Stage

Loan | Alive

Total Raised

$17.85M

Last Raised

$680K | 2 yrs ago

Mosaic Score

+30 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Deep 6 AI

Deep 6 AI finds patients for clinical trials in minutes rather than months. Using artificial intelligence and natural language processing on clinical data, Deep 6 AI's software accelerates patient recruitment exponentially, getting life-saving treatment to patients more quickly.

Deep 6 AI Headquarter Location

1055 East Colorado Blvd Suite 410

Pasadena, California, 91106,

United States

626-585-8586

ESPs containing Deep 6 AI

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Biopharmaceuticals

Companies in this market raise awareness of clinical trial opportunities and offer software that streamlines patient enrollment into a clinical trial. Solutions leverage varied approaches for finding patients, from AI for electronic health record (EHR) data to building disease-specific patient communities.

Deep 6 AI named as Outperformer among 15 other companies, including Deep Lens, Elligo Health Research, and TrialJectory.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Deep 6 AI's Products & Differentiation

See Deep 6 AI's products and how their products differentiate from alternatives and competitors

  • Deep 6 for Healthcare: Cohort Builder

    Cohort Builder: Self-service software for research staff to quickly find and validate patients for any study, across a health system’s patient population. Cohort Builder mines structured and unstructured data across all relevant clinical data sources (EHR, pathology, genomics, labs, etc.) to match patients against complex clinical trial eligibility criteria and allows for in-tool validation by showing evidence for each matched criterion. Entire study cohorts can be built and validated within minutes, based on the most recent clinical data.

    Differentiation

    Our AI/NLB mines structured and unstructured data to help access and comprehend all patient data across the multiple, disparate data systems in healthcare organizations 

    Easy to use system for validating evidence 

    Disease agnostic 

    Concept matching – represent patients as graphs allows researchers to leverage wider clinical context for matches 

    We allow searches with inclusion AND exclusion criteria• Everything performed in real-time 

    Connect all stakeholders in and out of organization 

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Research containing Deep 6 AI

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Deep 6 AI in 4 CB Insights research briefs, most recently on Aug 9, 2021.

Expert Collections containing Deep 6 AI

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Deep 6 AI is included in 5 Expert Collections, including Clinical Trials Tech.

C

Clinical Trials Tech

326 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

A

Artificial Intelligence

8,717 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

D

Digital Health

12,800 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

C

Clinical Trials Tech Market Map

108 items

This CB Insights Tech Market Map highlights 100+ clinical trials tech companies that are addressing 8 distinct technology priorities that pharmaceutical companies and CROs face.

B

Biopharma Tech

326 items

Latest Deep 6 AI News

08:00 EDT WCG and Deep 6 AI Announce Best-In-Class Partnership to Enable Faster, Smarter Clinical Trial Patient Recruitment

May 2, 2022

News provided by Share this article Share this article Partnership Will Combine Industry-Leading Solutions and Technologies to Enable Research Sponsors, CROs, and Investigative Sites to Accelerate Patient Enrollment, Increase Diversity in Clinical Trials, and Give Sites More Capacity to Conduct Efficient Clinical Trials PRINCETON, N.J. and PASADENA, Calif., May 2, 2022 /PRNewswire/ -- WCG and Deep 6 AI today announced that they are working together to drive more targeted patient recruitment in clinical trials and accelerate enrollment in vital medical research. The relationship brings together WCG's unique market position, serving over 3,300 research institutions and their investigative sites, over 5,000 biopharma sponsors, CROs, and Deep 6 AI's software, which connects over 28 million patients at over 2,000 healthcare facilities, to seamlessly and precisely match patients to clinical studies. As a result, WCG and Deep 6 AI's collaboration will enable clinical trials as a care alternative for more people and empower greater diversity among research participants. "As medical advances bring targeted therapies – especially in oncology – to smaller and more niche patient populations, clinical trials have become increasingly complex. Healthcare systems lack awareness of existing patients who could be matched to these studies and, similarly, research sponsors and their CRO partners lack the tools to locate eligible patients. Consequently, the vast majority of clinical trials fail to recruit enough participants, slowing down critical research and delaying access to life-saving treatments," said Nick Slack, MBE, President of WCG. "Our partnership with Deep 6 AI will bring together the expertise, capabilities, and technology to break down silos, connect research stakeholders, and enable trial sponsors, CROs, and investigative sites to find the right patients for the right studies at the right time. Ultimately, this will allow research teams to plan more effective clinical trials, launch studies sooner, quickly enroll eligible patients, and ensure patient and provider access to clinical trials is more equitable and diverse." Today, 80 percent of clinical trials are delayed due to their inability to properly recruit patients. To overcome these challenges, WCG and Deep 6 AI anticipate integrating their industry-leading offerings to provide a comprehensive solution that enables research teams to successfully meet patient recruitment goals, accelerate clinical trial enrollment, and get novel therapies to market faster. Specifically, the partnership will combine WCG's deep domain expertise, robust set of site-enabling capabilities, and unparalleled client relationships with Deep 6 AI's technology. The technology uses artificial intelligence (AI) concepts such as natural language processing (NLP) and machine learning (ML) on both structured and unstructured data across multiple systems to precisely match patients to clinical trials. "The majority of patients and their physicians are unaware of clinical trials opportunities, which means finding an eligible patient can be like finding a needle in a haystack," said Wout Brusselaers, CEO and Founder, Deep 6 AI. "In partnering with WCG, we're changing the paradigm, providing the industry with the technology, expertise, and resources to quickly match research criteria to patient characteristics. This comprehensive solution will make it possible for sponsors and CROs to easily determine which sites are best suited to participate in a study because they can know in advance whether they can identify,  recruit, and retain the right patients. This also provides a critical benefit to the sites in our network – they will know, before a trial opens, that they will be able to conduct an effective study. With such actionable information, there are huge advantages to those sites, sponsors, and CROs who choose to plug into our ecosystem." To learn more, contact Carmin Gade ( [email protected] ). Representatives from both companies will also be available at MAGI's Clinical Research Hybrid Conference - 2022 East , May 1-4, 2022, at the Sheraton Boston Hotel. Visit WCG at booth 201 and Deep 6 AI at booth 106 for additional information. About Deep 6 AI Deep 6 AI software accelerates research to the power of AI. The company uses artificial intelligence (AI) and natural language processing (NLP) on structured and unstructured data, to precision match patients to clinical trials in minutes instead of months. The platform connects sponsors, clinical researchers, physicians, and patients in a rapidly growing real-world ecosystem of premier research organizations. Deep 6 AI is a Techstars and StartX alum. The company was founded in 2016 and is based in Pasadena, CA. Learn more at https://deep6.ai . About WCG WCG is the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research. Comprised of two divisions, the industry's first central IRB – WCG IRB – and first clinical services organization, WCG enables biopharmaceutical companies, CROs, and institutions to advance the delivery of new treatments and therapies to patients, while maintaining the highest standards of human participant protection. For more information, please visit www.wcgirb.com, www.wcgclinical.com or follow us on Twitter @WCGClinical or LinkedIn. SOURCE WCG

Deep 6 AI Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Deep 6 AI Rank

  • When was Deep 6 AI founded?

    Deep 6 AI was founded in 2015.

  • Where is Deep 6 AI's headquarters?

    Deep 6 AI's headquarters is located at 1055 East Colorado Blvd, Pasadena.

  • What is Deep 6 AI's latest funding round?

    Deep 6 AI's latest funding round is Loan.

  • How much did Deep 6 AI raise?

    Deep 6 AI raised a total of $17.85M.

  • Who are Deep 6 AI's competitors?

    Competitors of Deep 6 AI include Ancora and 3 more.

  • What products does Deep 6 AI offer?

    Deep 6 AI's products include Deep 6 for Healthcare: Cohort Builder and 4 more.

You May Also Like

A
AllinCall

AllinCall provides Artificial Intelligence and Machine Learning based ChatBots and VoiceBots through various platforms like Web, Mobile, Alexa, Google Home, Google Assistant, Facebook, etc. Products built by AllinCall are currently being used by banks, insurance companies and AMCs across India. The company makes Sales.AI, a Sales-enablement Platform that uses a combination of Artificial and Human Intelligence to help businesses in assisting customers during the onboarding journey.

Massive Bio Logo
Massive Bio

Massive Bio is an AI powered platform that connects cancer patients and their treating oncologists to clinical trials while enabling pharmaceutical companies to get access to patients, mostly in community practices, and their information to speed up drug development.

M
MediMergent

MediMergent is a data collection and analytics company focused on Real-World Data (RWD) and Real-World Evidence (RWE) related to patients’ health status. MediMergent has built and deployed a digital platform that collects RWD from customized patient surveys, medical records, health insurance claims and billing data, pharmacy prescriptions and refill data, and, where appropriate, information from wearable medical devices and apps. MediMergent combines this data, acquired directly from the patients, that relate to first-hand accounts of their perceived risk versus benefit relationship for select medications, to generate a unique set of data or evidence (RWE) related to improve outcomes and reduce costs of healthcare. Using proprietary algorithms, MediMergent produces data that can be used by the entire healthcare ecosystem including prescribers, pharmacists, health insurers, pharmaceutical companies, corporations, regulators and importantly, patients.

SparkCognition Logo
SparkCognition

SparkCognition builds AI solutions for applications in energy, oil and gas, manufacturing, finance, aerospace, defense, and security. SparkCognition's products include Darwin for automated model building, DeepArmor for AI-built cybersecurity, SparkPredict, an analytics solution, and DeepLNP, a natural language processing solution.

Holon Solutions Logo
Holon Solutions

Holon Solutions surfaces patient data within the provider's workflow, with a bi-directional delivery mechanism. This helps providers to access critical patient information at the point of care, and retrieve the data needed to optimize patient outcomes and financial performance while managing contracts.

O
Oncoshot

Oncoshot provides clinical trials and treatment options for cancer patients. Oncoshot allows patients to share their data with trial institutes and sponsors and receive an immediate response, shortening the clinical trial search from weeks to minutes.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.